In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin

Antimicrobial Agents and Chemotherapy - Tập 43 Số 4 - Trang 782-788 - 1999
Yigong Ge1, Dorothy L. MacDonald1, Kenneth J. Holroyd1, Clyde Thornsberry2, Hannah M. Wexler3, Michael Zasloff1
1Magainin Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania 194621;
2MRL Pharmaceutical Services, Franklin, Tennessee 370642; and
3Wadsworth Anaerobe Laboratories, Los Angeles, California 900733

Tóm tắt

ABSTRACT Pexiganan, a 22-amino-acid antimicrobial peptide, is an analog of the magainin peptides isolated from the skin of the African clawed frog. Pexiganan exhibited in vitro broad-spectrum antibacterial activity when it was tested against 3,109 clinical isolates of gram-positive and gram-negative, anaerobic and aerobic bacteria. The pexiganan MIC at which 90% of isolates are inhibited (MIC 90 ) was 32 μg/ml or less for Staphylococcus spp., Streptococcus spp., Enterococcus faecium , Corynebacterium spp., Pseudomonas spp., Acinetobacter spp., Stenotrophomonas spp., certain species of the family Enterobacteriaceae , Bacteroides spp., Peptostreptococcus spp., and Propionibacterium spp. Comparison of the MICs and minimum bactericidal concentrations (MBCs) of pexiganan for 143 isolates representing 32 species demonstrated that for 92% of the isolates tested, MBCs were the same or within 1 twofold difference of the MICs, consistent with a bactericidal mechanism of action. Killing curve analysis showed that pexiganan killed Pseudomonas aeruginosa rapidly, with 10 6 organisms/ml eliminated within 20 min of treatment with 16 μg of pexiganan per ml. No evidence of cross-resistance to a number of other antibiotic classes was observed, as determined by the equivalence of the MIC 50 s and the MIC 90 s of pexiganan for strains resistant to oxacillin, cefazolin, cefoxitin, imipenem, ofloxacin, ciprofloxacin, gentamicin, and clindamicin versus those for strains susceptible to these antimicrobial agents. Attempts to generate resistance in several bacterial species through repeated passage with subinhibitory concentrations of pexiganan were unsuccessful. In conclusion, pexiganan exhibits properties in vitro which make it an attractive candidate for development as a topical antimicrobial agent.

Từ khóa


Tài liệu tham khảo

10.1016/0014-5793(90)81351-N

10.1146/annurev.iy.13.040195.000425

10.1128/AAC.42.5.1213

10.1016/0966-842X(94)90802-8

Groisman E. A. Aspedon A. The genetic basis of microbial resistance to antimicrobial peptides. Methods Mol. Biol. 78 1995 205 215

10.1046/j.1365-2958.1998.00757.x

10.1016/S0140-6736(97)80051-7

Iwahori A. Hirota Y. Sampe P. Miyano S. Takahashi N. Sasatsu M. Kondo I. Numao N. On the antibacterial activity of normal and reversed magainin 2 analogs against Helicobacter pylori. Biol. Pharm. Bull. 20 1997 805 808

Jacob L. Zasloff M. Potential therapeutic application of magainins and other antimicrobial agents for animal origin. Ciba Found. Symp. 186 1994 197 216

Lipsky B. A. Litka P. A. Zasloff M. Nelson K. the MSI-78-303 and 304 Study Group Microbial eradication and clinical resolution of infected diabetic foot ulcers treated with topical MSI-78 vs. oral ofloxacin abstr. LM-57 Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1997 374 American Society for Microbiology Washington D.C

Lorian V. Antibiotics in laboratory medicine. 1996 The Williams & Wilkins Co. Baltimore Md

Ludtke S. J. Heller W. Harroun T. A. Yang L. Huang H. W. Membrane pores induced by magainin. Biochemistry 35 1996 13723 13728

National Committee for Clinical Laboratory Standards Methods for determining bactericidal activity of antimicrobial agents. Proposed guideline (M26-P). Approved standard (M11-A3). 1987 National Committee for Clinical Laboratory Standards Wayne Pa

National Committee for Clinical Laboratory Standards Methods for antimicrobial susceptibility testing of anaerobic bacteria 3rd ed. Approved standard (M11-A3). 1993 National Committee for Clinical Laboratory Standards Wayne Pa

National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 4th ed. Approved standard (M7-A4). 1997 National Committee for Clinical Laboratory Standards Wayne Pa

10.1146/annurev.mi.49.100195.001425

Nissen-Meyer J. Nes I. F. Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action. Arch. Microbiol. 167 1997 67 77

10.1128/AAC.31.2.230

10.1126/science.7886453

10.1128/AAC.41.8.1738

10.1073/pnas.94.16.8686

Tytler E. M. Anantharamaiah G. M. Walker D. E. Mishra V. K. Palgunachari M. N. Segrest J. P. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry 34 1995 4393 4401

10.1073/pnas.87.12.4761

Wenk M. R. Seelig J. Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation. Biochemistry 37 1998 3909 3916

Wright S. Personal communication.

10.1073/pnas.84.15.5449

Zasloff M. D. MacDonald and Y. Ge. Unpublished data.

Thông tin
Thông tin xuất bản

Antimicrobial Agents and Chemotherapy

Tập 43 Số 4

782-788

Thông tin tác giả